Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3740)
All Articles published online
|
Jan 28, 2010 (publication date) through Apr 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu SD, Wang JY, Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: A comparative study. World J Gastroenterol 2010; 16(4): 501-507 [PMID: 20101779 DOI: 10.3748/wjg.v16.i4.501] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i4/501.htm |
| Number | Citing Articles |
| 1 |
Yuanyuan Li, Yu Chen, Ying Zhao, Robert Lane. Schmidt. The Diagnostic Value of the FIB-4 Index for Staging Hepatitis B-Related Fibrosis: A Meta-Analysis. PLoS ONE 2014; 9(8): e105728 doi: 10.1371/journal.pone.0105728
|
| 2 |
Sreemanta Madhab Baruah, Hrisikesh Sarma, Monigopa Das, Parama Nanda Taye, Imdadul Hossain. A STUDY OF PREVALENCE OF THROMBOCYTOPENIA IN CHRONIC HEPATITIS B PATIENTS AND ITS ASSOCIATION WITH THE SEVERITY OF HEPATIC FIBROSIS IN A TERTIARY CARE HOSPITAL OF NORTH EAST INDIA.. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2023; : 75 doi: 10.36106/ijsr/6102588
|
| 3 |
C Rinaldi A Lesmana, Simon Salim, Irsan Hasan, Andri S Sulaiman, Rino A Gani, Levina S Pakasi, Laurentius A Lesmana, Ening Krisnuhoni, Unggul Budihusodo. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: The role in primary care setting. Journal of Clinical Pathology 2011; 64(10): 916 doi: 10.1136/jclinpath-2011-200044
|
| 4 |
Xie Er Liang, Chunxiu Zhong, Liwen Huang, Shuling Yang, Youfu Zhu, Yongpeng Chen, Jinlin Hou. Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers. Journal of Gastroenterology and Hepatology 2017; 32(2): 459 doi: 10.1111/jgh.13475
|
| 5 |
Sheng-di Wu, Yan-jun Ni, Li–li Liu, Hai Li, Lun-gen Lu, Ji-Yao Wang. Establishment and validation of a simple noninvasive model to predict significant liver fibrosis in patients with chronic hepatitis B. Hepatology International 2012; 6(1): 360 doi: 10.1007/s12072-011-9328-1
|
| 6 |
Manas K. Behera, Girish K. Pati, Jimmy Narayan, Debakanta Mishra, Lalit K. Meher, Ayaskant Singh, Kanishka Uthansingh, Manoj K. Sahu. Tenofovir is Superior to Entecavir in Patients with Treatment-naïve Hepatitis B e-Antigen–Positive Chronic Hepatitis B. Journal of Clinical and Experimental Hepatology 2021; 11(1): 37 doi: 10.1016/j.jceh.2020.05.003
|
| 7 |
Curtis Cooper, Matt Driedger, David Wong, Sarah Haylock‐Jacobs, Abdel Aziz Shaheen, Carla Osiowy, Scott Fung, Karen Doucette, Alexander Wong, Lisa Barrett, Brian Conway, Alnoor Ramji, Gerald Minuk, Giada Sebastiani, Philip Wong, Carla S. Coffin. Distinct Hepatitis B and HIV co‐infected populations in Canada. Journal of Viral Hepatitis 2021; 28(3): 517 doi: 10.1111/jvh.13453
|
| 8 |
Federica Branchi, Clara Benedetta Conti, Alessandra Baccarin, Pietro Lampertico, Dario Conte, Mirella Fraquelli. Non-invasive assessment of liver fibrosis in chronic hepatitis B. World Journal of Gastroenterology 2014; 20(40): 14568-14580 doi: 10.3748/wjg.v20.i40.14568
|
| 9 |
Ki Tae Suk, Dae Yong Kim, Kyoung Min Sohn, Dong Joon Kim. . Advances in Clinical Chemistry 2013; 62: 33 doi: 10.1016/B978-0-12-800096-0.00002-0
|
| 10 |
Xue-Ying Xu, Hong Kong, Rui-Xiang Song, Yu-Han Zhai, Xiao-Fei Wu, Wen-Si Ai, Hong-Bo Liu, Anand S. Mehta. The Effectiveness of Noninvasive Biomarkers to Predict Hepatitis B-Related Significant Fibrosis and Cirrhosis: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. PLoS ONE 2014; 9(6): e100182 doi: 10.1371/journal.pone.0100182
|
| 11 |
Seán J. Costelloe, Eleni Theocharidou, Emmanuel Tsochatzis, Evangelos Thalassinos, Nicholas Martin, Guiseppe Fede, Michael Thomas, Anthony K. Burroughs. Hepascore and hyaluronic acid as markers of fibrosis in liver disease of mixed aetiology. European Journal of Gastroenterology & Hepatology 2015; 27(3): 313 doi: 10.1097/MEG.0000000000000267
|
| 12 |
Xueying Xu, Wusheng Wang, Qimeng Zhang, Weijie Cai, Mingcheng Wu, Tiantian Qin, Hongbo Liu. A Generic Nomogram Predicting the Stage of Liver Fibrosis Based on Serum Biochemical Indicators Among Chronic Hepatitis B Patients. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.669800
|
| 13 |
Xue-Ying Xu, Wu-Sheng Wang, Qi-Meng Zhang, Jun-Ling Li, Jin-Bin Sun, Tian-Tian Qin, Hong-Bo Liu. Performance of common imaging techniques <i>vs</i> serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. World Journal of Clinical Cases 2019; 7(15): 2022-2037 doi: 10.12998/wjcc.v7.i15.2022
|
| 14 |
Tarek A Besheer, Mahmoud M El-Bendary, Khaled R Zalata, Hossam E Zaghalol. Evaluation of Fibrosis Progression by
Noninvasive Biochemical Markers in
Egyptian Patients with Chronic Hepatitis B. Euroasian Journal of Hepato-Gastroenterology 2011; 1(2): 71 doi: 10.5005/jp-journals-10018-1016
|
| 15 |
Erkin Oztas, Ufuk Baris Kuzu, Neslihan Inci Zengin, Ismail Hakki Kalkan, Fatih Saygili, Hakan Yildiz, Huseyin Tugrul Celik, Meral Akdogan, Mesut Yalin Kilic, Aydin Seref Koksal, Bulent Odemis, Nuretdin Suna, Ertugrul Kayacetin. Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?. Medicine 2015; 94(47): e1889 doi: 10.1097/MD.0000000000001889
|
| 16 |
Yi Huang, Gary P. Jeffrey, Leon A. Adams. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_29-1
|
| 17 |
Hong-Bo Liu, Jian-Ping Zhou, Yong Zhang, Xiao-Hui Lv, Wei Wang. Prediction on liver fibrosis using different APRI thresholds when patient age is a categorical marker in patients with chronic hepatitis B. Clinica Chimica Acta 2011; 412(1-2): 33 doi: 10.1016/j.cca.2010.08.032
|
| 18 |
Giada Sebastiani, Konstantinos Gkouvatsos, Mario Plebani. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine. cclm 2011; 49(1): 13 doi: 10.1515/CCLM.2011.001
|
| 19 |
Jieyao Cheng, Jinlin Hou, Huiguo Ding, Guofeng Chen, Qing Xie, Yuming Wang, Minde Zeng, Xiaojuan Ou, Hong Ma, Jidong Jia, Seung Up Kim. Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B. PLOS ONE 2015; 10(12): e0144425 doi: 10.1371/journal.pone.0144425
|
| 20 |
Papa Saliou Mbaye, Anna Sarr, Jean-Marie Sire, Marie-Louise Evra, Adama Ba, Jean Daveiga, Aboubakry Diallo, Fatou Fall, Loic Chartier, François Simon, Muriel Vray, Young Nyun Park. Liver Stiffness Measurement and Biochemical Markers in Senegalese Chronic Hepatitis B Patients with Normal ALT and High Viral Load. PLoS ONE 2011; 6(7): e22291 doi: 10.1371/journal.pone.0022291
|
| 21 |
Kenji Ikeda, Namiki Izumi, Eiji Tanaka, Hiroshi Yotsuyanagi, Yoshihisa Takahashi, Junichi Fukushima, Fukuo Kondo, Toshio Fukusato, Kazuhiko Koike, Norio Hayashi, Hiromitsu Kumada. Fibrosis score consisting of four serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B. Hepatology Research 2013; 43(6): 596 doi: 10.1111/j.1872-034X.2012.01115.x
|
| 22 |
Yun‐hao Xun, Guo‐qing Zang, Jian‐chun Guo, Xiu‐li Yu, Hong Liu, Jing Xiang, Jing Liu, Jun‐ping Shi. Serum hepatitis B surface antigen quantification as a useful assessment for significant fibrosis in hepatitis B e antigen‐positive hepatitis B virus carriers. Journal of Gastroenterology and Hepatology 2013; 28(11): 1746 doi: 10.1111/jgh.12304
|
| 23 |
Angela Assal, David Mackie, Curtis L. Cooper. Transient elastography, APRI, and ultrasound have minimal utility in chronic low-replicative hepatitis B infection. European Journal of Gastroenterology & Hepatology 2014; 26(9): 1010 doi: 10.1097/MEG.0000000000000165
|
| 24 |
Da-Wu Zeng, Jing Dong, Yu-Rui Liu, Jia-Ji Jiang, Yue-Yong Zhu. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World Journal of Gastroenterology 2016; 22(29): 6663-6672 doi: 10.3748/wjg.v22.i29.6663
|
| 25 |
Ömer Başar, Barış Yımaz, Fuat Ekiz, Zeynep Giniş, Akif Altınbaş, Bora Aktaş, Yaşar Tuna, Şahin Çoban, Namık Delibaş, Osman Yüksel. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results. Clinics and Research in Hepatology and Gastroenterology 2013; 37(2): 152 doi: 10.1016/j.clinre.2012.07.003
|
| 26 |
Bingtian Dong, Guorong Lyu, Yuping Chen, Guofu Lin, Huaming Wang, Ran Qin, Jionghui Gu. Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis. Expert Review of Gastroenterology & Hepatology 2021; 15(9): 1077 doi: 10.1080/17474124.2021.1880894
|
| 27 |
Zhi Yin, Jin Zou, Qiongxuan Li, Lizhang Chen. Diagnostic value of FIB-4 for liver fibrosis in patients with hepatitis B: a meta-analysis of diagnostic test. Oncotarget 2017; 8(14): 22944 doi: 10.18632/oncotarget.14430
|
| 28 |
H. Ben Ayed, M. Koubaa, S. Yaich, K. Rekik, T. Ben Jemaa, I. Maaloul, C. Marrekchi, J. Damak, M. Ben Jemaa. A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection. Médecine et Maladies Infectieuses 2019; 49(8): 607 doi: 10.1016/j.medmal.2019.02.004
|
| 29 |
Yi Huang, Leon A. Adams, John Joseph, Max K. Bulsara, Gary P. Jeffrey. The ability of Hepascore to predict liver fibrosis in chronic liver disease: a meta‐analysis. Liver International 2017; 37(1): 121 doi: 10.1111/liv.13116
|
| 30 |
Urvi Rana, Matt Driedger, Paul Sereda, Shenyi Pan, Erin Ding, Alex Wong, Sharon Walmsley, Marina Klein, Deborah Kelly, Mona Loutfy, Rejean Thomas, Stephen Sanche, Abigail Kroch, Nima Machouf, Marie-Helene Roy-Gagnon, Robert Hogg, Curtis L. Cooper. Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4617-8
|
| 31 |
TY Jiang, JH Hou, B Su, T Zhang, Y Yang, ZY Liu, W Wang, CP Guo, LL Dai, LJ Sun, H Wu. Demographic and clinical factors associated with immune reconstitution in HIV/HBV co‐infected and HIV mono‐infected patients: a retrospective cohort study. HIV Medicine 2020; 21(11): 722 doi: 10.1111/hiv.13023
|
| 32 |
Jihene Bergaoui, Imed Latiri, Houda Chaouch, Jihene Ben Abdallah, Sawssen Mrad, Wided Maatamri, Amel Letaief, Helmi Ben Saad. Evaluation of muscle strength and quality in North African patients with chronic hepatitis B: A pilot case control study. Libyan Journal of Medicine 2023; 18(1) doi: 10.1080/19932820.2023.2204564
|
| 33 |
Wenwen Jin, Zhonghua Lin, Yongning Xin, Xiangjun Jiang, Quanjiang Dong, Shiying Xuan. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-14
|
| 34 |
Paul Calès, Jérôme Boursier, Sandrine Bertrais, Frédéric Oberti, Yves Gallois, Isabelle Fouchard-Hubert, Nina Dib, Jean-Pierre Zarski, Marie Christine Rousselet. Optimization and robustness of blood tests for liver fibrosis and cirrhosis. Clinical Biochemistry 2010; 43(16-17): 1315 doi: 10.1016/j.clinbiochem.2010.08.010
|
| 35 |
Alassan Kouamé Mahassadi, Alain Koffi Attia, Fulgence M. Yao Bathaix, Narcisse Baudouin Agbé, Stanislas Doffou, Henriette Ya Kissi, Isidore Mouhenou Diomandé, Paul Cales, Thérese Ndri-Yoman. Diagnostic accuracy of biochemical markers of fibrosis in black African patients with chronic hepatitis B. Health 2010; 2(12): 1413 doi: 10.4236/health.2010.212210
|
| 36 |
Rong-yun Mai, Jie Zeng, Yi-shuai Mo, Rong Liang, Yan Lin, Su-su Wu, Xue-min Piao, Xing Gao, Guo-bin Wu, Le-qun Li, Jia-zhou Ye. <p>Artificial Neural Network Model for Liver Cirrhosis Diagnosis in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma</p>. Therapeutics and Clinical Risk Management 2020; : 639 doi: 10.2147/TCRM.S257218
|
| 37 |
Tali Shaltiel, Umut Sarpel, Andrea D. Branch. The adverse characteristics of hepatocellular carcinoma in the non‐cirrhotic liver disproportionately disadvantage Black patients. Cancer Medicine 2024; 13(3) doi: 10.1002/cam4.6654
|
| 38 |
Zeinab Babaei, Hadi Parsian. Hyaluronic acid algorithm-based models for assessment of liver fibrosis: translation from basic science to clinical application. Hepatobiliary & Pancreatic Diseases International 2016; 15(2): 131 doi: 10.1016/S1499-3872(16)60062-0
|
| 39 |
Yi Huang, Gary P. Jeffrey, Leon A. Adams. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 23 doi: 10.1007/978-94-007-7675-3_29
|
| 40 |
Fatma Demet Arslan, Inanc Karakoyun, Bengu Tatar, Emel Ebru Pala, Mustafa Yıldırım, Celal Ulasoglu, Can Duman, Harun Akar, Sukran Kose, Banu Isbilen Basok. SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B. Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.63310
|